Kevin Henry has resigned as group finance director of Airea. He will leave the flooring company on 28 August 2009. A successor has yet to be appointed but in the short term, Roger Salt has added the role of company secretary to his existing duties as finance director – operations.Geoffrey Smith has resigned as finance director of Fulcrum Pharma. He will leave the company on 30 June 2009. Barry Knight has been appointed chief financial officer and as a director of Fulcrum Pharma in succession to Smith. Knight was most recently finance and administration director of KeyMed and CFO of Trigen and Trigen Holdings.
Bradford & Bingley has confirmed that its group finance director, Chris Willford, will step down on 30 June 2009.Allan Watson has been appointed chief financial officer of pharmaceutical company ProStrakan. He replaces Paul Garvey. Watson joins the firm from medical technology company Optos, where he has been CFO since 2003.